| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| North America (Primary) | PRIMARYNOAM | Univ | 7,783 | 74,818,897 | 0.18% | 1.71% | -3.95% | -4.31% | -1.42% | 26.75% |
| Healthcare | HEALTHCARE | Sector | 1,212 | 6,835,435 | -0.56% | 1.10% | -5.40% | -6.58% | 3.05% | 14.17% |
| Biopharmaceuticals | BIOPHARMA | SubSec | 608 | 3,778,036 | -1.18% | 1.94% | -3.75% | 1.74% | 15.37% | 40.68% |
| System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 288 | 1,464,681 | -1.50% | 3.16% | -4.38% | -7.98% | 10.29% | 32.28% |
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| Ophthalmology Biopharmaceuticals | OPHTHALMOLOGY | SubInd | 17 | 17,797 | -0.97% | 23.08% | 14.59% | 26.90% | 65.31% | 82.28% |
| Cardiovascular System Biopharmaceuticals | CARDIOVASCULAR | SubInd | 18 | 42,866 | -0.28% | 5.73% | 9.63% | 8.08% | 19.73% | 103.04% |
| Digestive System Biopharmaceuticals | DIGESTIVE | SubInd | 24 | 27,830 | 0.98% | 5.16% | 6.69% | -2.26% | 26.25% | 111.61% |
| Urology Biopharmaceuticals | UROLOGY | SubInd | 12 | 6,959 | -0.65% | 5.42% | 4.19% | -13.16% | -13.10% | 38.80% |
| Dermatology Biopharmaceuticals | DERMATOLOGY | SubInd | 25 | 32,952 | 0.95% | 6.67% | 4.11% | 9.66% | 40.82% | 112.84% |
| Hematology Biopharmaceuticals | HEMATOLOGY | SubInd | 14 | 43,274 | 1.39% | 3.39% | 2.15% | -1.34% | 1.89% | 47.92% |
| Neurology Biopharmaceuticals | NEUROLOGY | SubInd | 93 | 149,835 | -0.83% | 1.04% | 1.18% | 3.98% | 22.24% | 59.90% |
| S&P 500 | SPY:USASPY:USA | Benchmark | 14,024 | 95,926,309 | 0.09% | 1.66% | -4.02% | -3.74% | -1.44% | 17.51% |
| System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 288 | 1,464,681 | -1.50% | 3.16% | -4.38% | -7.98% | 10.29% | 32.28% |
| Endocrinology and Metabolism Biopharmaceuticals | ENDOCRINOLOGY | SubInd | 34 | 986,894 | -1.94% | 3.86% | -6.22% | -11.94% | 6.52% | 28.95% |
| Obstetrics and Gynecology Biopharmaceuticals | OBSTETRICS | SubInd | 1 | 23 | 0.00% | -9.91% | -7.41% | -1.96% | 60.67% | 36.90% |
| Respiratory System Biopharmaceuticals | RESPIRATORY | SubInd | 15 | 119,238 | -1.84% | -2.99% | -7.42% | -6.28% | 6.17% | -7.79% |
| Immunology Biopharmaceuticals | IMMUNOLOGY | SubInd | 31 | 36,217 | -0.28% | -1.29% | -10.08% | -0.84% | 10.87% | 41.17% |
| Musculoskeletal System Biopharmaceuticals | MUSCULOSKELETAL | SubInd | 4 | 796 | -1.89% | 6.39% | -13.43% | -14.40% | -21.86% | 16.91% |
* Colors indicate performance relative to the benchmark.